Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126407431 | 12640743 | 1 | I | 20160801 | 20160810 | 20160810 | EXP | TR-MYLANLABS-2016M1032572 | MYLAN | TURSUN I, TAZEGUL G, KARHAN O, GUNES N, ULUKAL E, ATCAKARLAR MA, ET AL. POLYPHARMACY MAY BE THE CAUSE OF ACUTE LITHIUM INTOXICATION AT THE SECOND DAY OF TREATMENT. FOLIA-MED 2016;57:261-3. | 0.00 | Y | 0.00000 | 20160810 | OT | TR | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126407431 | 12640743 | 1 | PS | LITHIUM. | LITHIUM | 1 | Oral | 900 MG, QD | Y | U | 202288 | 900 | MG | QD | |||||
| 126407431 | 12640743 | 2 | I | QUETIAPINE. | QUETIAPINE | 1 | Unknown | 400 MG, QD | Y | U | 0 | 400 | MG | QD | |||||
| 126407431 | 12640743 | 3 | I | HYDROCHLOROTHIAZIDE/VALSARTAN | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Unknown | 160 MG, QD | Y | U | 0 | 160 | MG | QD | |||||
| 126407431 | 12640743 | 4 | C | ANTI-PARKINSON | UNSPECIFIED INGREDIENT | 1 | Unknown | 250 MG, BID | Y | U | 0 | 250 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126407431 | 12640743 | 1 | Product used for unknown indication |
| 126407431 | 12640743 | 2 | Product used for unknown indication |
| 126407431 | 12640743 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126407431 | 12640743 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126407431 | 12640743 | Confusional state | |
| 126407431 | 12640743 | Disorientation | |
| 126407431 | 12640743 | Drug interaction | |
| 126407431 | 12640743 | Dysarthria | |
| 126407431 | 12640743 | Muscle contractions involuntary | |
| 126407431 | 12640743 | Muscle rigidity | |
| 126407431 | 12640743 | Nausea | |
| 126407431 | 12640743 | Stupor | |
| 126407431 | 12640743 | Toxicity to various agents | |
| 126407431 | 12640743 | Unresponsive to stimuli | |
| 126407431 | 12640743 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |